AMP Issues New Joint Guidelines to Standardize Interpretation and Reporting...
AMP has published guideline recommendations for both clinical laboratory professionals and oncologists that assess the status of next-generation sequencing (NGS)-based cancer tests and establish...
View ArticleAMP Issues Best Practice Guidelines for Next-Generation Sequencing-Based...
AMP has published consensus recommendations that will help clinical laboratory professionals achieve high-quality sequencing results and deliver better care for cancer patients
View ArticleThe Association for Molecular Pathology to Recognize Andrew P. Feinberg, MD,...
Epigenetics pioneer to receive Association's highest honor at upcoming Annual Meeting
View ArticleThe Association for Molecular Pathology Announces Results of 2017 Leadership...
The Association for Molecular Pathology (AMP) has announced the results of its 2017 Leadership Elections.
View ArticleThe Association for Molecular Pathology Announces 2017 Award Recipients
September 5, 2017 - The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostics professionals, today announced the recipients of this year's...
View ArticleAMP Issues Consensus Clinical Validation Guideline Recommendations for...
The Association for Molecular Pathology, the premier global, non-profit molecular diagnostics professional society, today published 17 consensus recommendations to help clinical laboratory...
View ArticleAMP Publishes Recommendations for Clinical CYP2C19 Genotyping Allele Selection
AMP has published consensus, evidence-based recommendations to aid clinical laboratory professionals when designing and validating clinical CYP2C19 assays, promote standardization of testing across...
View ArticleAMP Addresses Clinical Relevance of DNA Variants in Chronic Myeloid Neoplasms
AMP has published consensus, evidence-based recommendations to aid clinical laboratory professionals with the management of most Chronic Myeloid Neoplasms (CMNs) and development of high-throughput...
View ArticleAssociation for Molecular Pathology Announces 2018 Award Recipients
AMP has announced the recipients of this year's Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award. These prestigious accolades will be...
View ArticleMore than 60 Leading Health Care Organizations Call on CMS to Maintain...
Leading health care companies and organizations representing patients, providers, academic medical centers, laboratories, and diagnostic manufacturers urged the Centers for Medicare and Medicaid...
View ArticleAMP Recommends Minimum Set of Alleles for All Clinical CYP2C9 Genotyping Testing
A new joint report from AMP and CAP shares consensus, evidence-based recommendations to aid in the design and validation of clinical CYP2C9 assays, promote standardization of testing across different...
View ArticleAssociation for Molecular Pathology Expresses Serious Concerns with Congress'...
AMP has expressed serious concerns with Congress' recent proposal to amend Section 101 of the Patent Act. If enacted, the draft legislation would overturn 150 years of patent case law and permit...
View ArticleAMP Bolsters Position on Consumer Genomic Testing
AMP has revised its official position for all consumer genomic testing. Based on a recent assessment of the current market landscape and privacy best practices, the latest position statement features...
View ArticleAMP Recommends Clinical Pharmacogenomic Testing Best Practices to Preserve...
AMP has published a new position statement for pharmacogenomic testing. Based on a recent assessment of the current market landscape, the statement includes a list of criteria for laboratories to...
View ArticleAssociation for Molecular Pathology Announces 2019 Award Recipients
AMP has announced the recipients of this year's Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award. These prestigious accolades will be...
View ArticleAssociation for Molecular Pathology Calls on Senate to Close Coverage Gaps...
The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released a statement on H.R. 6201, the Families First Coronavirus Response Act, as...
View ArticleAssociation for Molecular Pathology Commends Senator Rand Paul for...
AMP applauds US Senator Rand Paul (R-KY) for introducing new legislation to allow molecular pathology professionals to continue advancing and offering laboratory developed testing procedures (LDPs) for...
View ArticleAMP Expresses Support for Citizen Petition from the Coalition to Preserve...
AMP has submitted a formal response in support of the Citizen Petition from Hyman, Phelps & McNamara, P.C. on behalf of the Coalition to Preserve Access to Pharmacogenomics (PGx) Information. The...
View ArticleAMP Recommends Minimum Set of Pharmacogenetic Alleles to Help Standardize...
AMP has published consensus, evidence-based recommendations to aid in the design, validation and interpretation of clinical genotyping tests for the prediction of warfarin response. The manuscript,...
View ArticleAssociation for Molecular Pathology Releases Preliminary Results to...
The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the preliminary results of its April 2020 SARS-CoV-2 Testing Survey for...
View Article